Search results
Showing 226 to 240 of 795 results for mental health
Evidence-based recommendations on electroconvulsive therapy (ECT) for treating catatonia, prolonged or severe manic episodes or schizophrenia in adults.
This quality standard covers preventing further cardiovascular disease after a myocardial infarction (heart attack). It includes assessment and cardiac rehabilitation. It describes high-quality care in priority areas for improvement.
View quality statements for QS99Show all sections
Sections for QS99
- Quality statements
- Quality statement 1: Assessment of left ventricular function
- Quality statement 2: Referral for cardiac rehabilitation
- Quality statement 3: Communication with primary care
- Quality statement 4: Cardiac rehabilitation – assessment appointment
- Quality statement 5 (developmental): Options for cardiac rehabilitation
- Update information
- About this quality standard
interviews shows high levels of sickness absence and negative impact on mental health and wellbeing due to the emotional pressures of...
the UK, how prevalent is coexisting severe mental illness with substance misuse and what are the physical health, social...
Esketamine nasal spray for treatment-resistant depression (TA854)
Evidence-based recommendations on esketamine (Spravato) for treatment-resistant depression in adults.
Learning disability: care and support of people growing older (QS187)
This quality standard covers identifying, assessing and regularly reviewing the care and support needs of people with a learning disability as they grow older. People with a learning disability have many of the same age-related health and social care needs as other people, but this quality standard focuses on the specific challenges associated with their learning disability. It describes high-quality care in priority areas for improvement.
View quality statements for QS187Show all sections
This guideline covers assessing and managing motor neurone disease (MND). It aims to improve care from the time of diagnosis, and covers information and support, organisation of care, managing symptoms and preparing for end of life care.
provided to asylum-seeking children and young people, including links to health services. The principal social worker uses NICE's...
Evidence-based recommendations on baricitinib (Olumiant) for treating severe alopecia areata in adults.
In development Reference number: GID-QS10196 Expected publication date: 28 January 2027
children and young people who have been identified as needing additional mental health support? Any explanatory notes(if applicable) For...
effective de-escalatory actions, interactions and activities used by mental health nurses, including the most effective and efficient...
Alcohol interventions in secondary and further education (NG135)
This guideline covers interventions in secondary and further education to prevent and reduce alcohol use among children and young people aged 11 up to and including 18. It also covers people aged 11 to 25 with special educational needs or disabilities in full-time education. It will also be relevant to children aged 11 in year 6 of primary school.
to allow 'walking across' from one assessment instrument for common mental health disorders to another? Any explanatory notes(if...
Science policy projects with NICE.